Meeting
2023 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer survival outcomes in Appalachian Kentucky.
Authors
Deepali Pandey
University of Kentucky, Lexington, KY
Deepali Pandey , Quan Chen , Bin Huang , Zin Myint , Peng Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Cancer Disparities
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 39)
DOI
10.1200/JCO.2023.41.6_suppl.39
Abstract #
39
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Effect of docetaxel (D) use on survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with novel hormonal therapies (NHTs): A meta-analysis.
First Author: Deniz Can Guven
Poster
2015 ASCO Annual Meeting
Overall survival in patients with Hodgkin lymphoma: Disparities by insurance status.
First Author: Rahul Parikh
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world (RW) survival and outcomes with androgen receptor pathway inhibitor (ARPI) –doublet therapy in patients (pts) with de novo metastatic castration-sensitive prostate cancer (mCSPC).
First Author: Joshua Parrish
Poster
2024 ASCO Genitourinary Cancers Symposium
Survival outcomes for rural patients with advanced prostate cancer: A SEER investigation.
First Author: Liang G Qu